Innate Immunomodulation and Inflammation: From Molecular Mechanisms to Pre-Clinical Insights
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 4868
Special Issue Editors
Interests: mast cell biology; inflammation; innate immunity at the oral mucosa
Interests: the interaction between chronic viral infections and the host innate immune system in carcinogenesis; type I interferons-mediated innate immune system; DNA damage response; autophagy; oxidative stress
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit and contribute with your original research and review articles to the upcoming Special Issue, “Innate Immunomodulation and Inflammation,” in the peer-reviewed, open access journal Biomolecules.
The innate immune system constitutes the first line of defense that offers immediate protection against bacterial and viral infection. Further, cells of the innate immune system recognize “danger” signals generated following cell stress, injury and trauma, aging, and cancer. Once activated, innate immunity plays a fundamental role in priming the adaptive immune system for specific and targeted responses that contribute to tissue repair, good health, and survival.
In recent years, there has been an increased understanding of mediators of inflammatory responses and the role of immune checkpoints in the modulation of immune responses. This has led to the development of effective biological agents and therapies that enhance the function of T cells. However, it has now become evident that modulating the function of innate immune cells can also have therapeutic effects. Exciting new studies are providing evidence to support the notion that targeting co-inhibitory or co-stimulatory receptors on innate immune cells, or even modulation of the microbiome, has remarkable potential for therapies not only in cancer but also in autoimmune disease, inflammation, and chronic infection.
The aims of this Special Issue are as follows:
- To define new biomarkers for diseases associated with innate immune cells.
- To highlight novel studies on the characterization of the pharmacological mechanisms of new drugs targeting innate immune cells.
- To showcase the potential of new approaches to modulate innate immune responses for the development of therapies for cancer, autoimmunity, inflammation, and chronic infectious diseases.
For this Special Issue, basic research, in vitro and in vivo investigations, and pre-clinical studies examining the effects of innate cell modulation are welcome.
We look forward to receiving your contributions.
Dr. Fabián Flores-Borja
Dr. Shunbin Ning
Prof. Dr. Michael Torzewski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- innate immunity
- therapy
- immune checkpoints
- cancer
- autoimmunity
- inflammation
- infection
- danger-associated molecular patterns
- pattern recognition receptors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
